Gelesis Holdings Operating Income 2021-2022 | GLS
Gelesis Holdings operating income from 2021 to 2022. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Gelesis Holdings Annual Operating Income
(Millions of US $) |
| 2021 |
$-21 |
| 2020 |
$-2 |
| 2019 |
$ |
Gelesis Holdings Quarterly Operating Income
(Millions of US $) |
| 2022-03-31 |
$-43 |
| 2021-12-31 |
$0 |
| 2021-09-30 |
$-1 |
| 2021-06-30 |
$-0 |
| 2021-03-31 |
$-17 |
| 2020-12-31 |
|
| 2020-09-30 |
$-0 |
| 2020-06-30 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.122B |
$0.011B |
|
Gelesis is a consumer-centered biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Gelesis, formerly known as Capstar Special Purpose Acquisition Corp., is based in BOSTON.
|
